Item 2.02 Results of Operations and Financial Condition.

On January 9, 2022, RxSight, Inc. (the "Company") issued a press release announcing preliminary unaudited fourth quarter and full year 2021 financial and operational results. A copy of the press release is furnished herewith as Exhibit 99.1.

The information furnished in this Current Report on Form 8-K under Item 2.02 and the exhibit attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or in any filing under the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 7.01 Regulation FD Disclosure.

Channels for Disclosure of Information

Investors and others should note that the Company may announce material information to the public through filings with the Securities and Exchange Commission, its website (www.rxsight.com), press releases, public conference calls, and public webcasts. The Company uses these channels, as well as social media, to communicate with the public about the Company, its products and other matters. As such, investors, the media and others are encouraged to review the information disclosed through the Company's social media and other channels listed above as such information could be deemed to be material information. Please note that this list may be updated from time to time.

Item 9.01 Financial Statements and Exhibits.





Exhibit    Description
number
99.1         Press Release dated January 9, 2022.
104        Cover Page Interactive Data File (embedded within the inline XBRL
           document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses